BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32058275)

  • 1. ROR-α-1 inhibits the proliferation, invasion, and migration of hepatocellular carcinoma MHCC97H via downregulation of chemokine CXCL5.
    Liu G; Yang ZF; Zhou PY; Zhou C; Guan RY; Sun BY; Fan J; Zhou J; Yi Y; Qiu SJ
    Cytokine; 2020 May; 129():155004. PubMed ID: 32058275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis.
    Yao Z; Xiong Z; Li R; Liang H; Jia C; Deng M
    Biomed Pharmacother; 2018 Aug; 104():102-109. PubMed ID: 29772429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
    He Y; He X
    Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-1277 Inhibits Proliferation and Migration of Hepatocellular Carcinoma HepG2 Cells by Targeting and Suppressing BMP4 Expression and Reflects the Significant Indicative Role in Hepatocellular Carcinoma Pathology and Diagnosis After Magnetic Resonance Imaging Assessment.
    Cao X; Xu L; Liu Q; Yang L; Li N; Li X
    Oncol Res; 2019 Feb; 27(3):301-309. PubMed ID: 29562958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway.
    Chen L; Guo P; He Y; Chen Z; Chen L; Luo Y; Qi L; Liu Y; Wu Q; Cui Y; Fang F; Zhang X; Song T; Guo H
    Cell Death Dis; 2018 May; 9(5):513. PubMed ID: 29725020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of miR-99b in mediating hepatocellular carcinoma invasion and migration.
    Liu CJ; Yang JH; Huang FZ; Yang JH; Liu CP; Mao XH; Yi WM; Shen XB; Peng C; Chen MF; Jiang B; Wu JS
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2273-2281. PubMed ID: 29762829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-139 inhibits hepatocellular carcinoma cell growth through down-regulating karyopherin alpha 2.
    Zan Y; Wang B; Liang L; Deng Y; Tian T; Dai Z; Dong L
    J Exp Clin Cancer Res; 2019 May; 38(1):182. PubMed ID: 31046781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
    Fei X; Zhang P; Pan Y; Liu Y
    Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
    Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
    Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour-suppressive role of PTPN13 in hepatocellular carcinoma and its clinical significance.
    Zhan H; Jiang J; Luo C; Sun Q; Ke A; Sun C; Hu J; Hu Z; Hu B; Zhu K; Fan J; Zhou J; Huang X
    Tumour Biol; 2016 Jul; 37(7):9691-8. PubMed ID: 26801674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA‑130a inhibits the proliferation, migration and invasive ability of hepatocellular carcinoma cells by downregulating Rho‑kinase 2.
    Zheng Y; Xiang L; Chen M; Xiang C
    Mol Med Rep; 2018 Sep; 18(3):3077-3084. PubMed ID: 30015839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4.
    Yang X; Sun L; Wang L; Yao B; Mo H; Yang W
    Biomed Pharmacother; 2019 Oct; 118():109386. PubMed ID: 31545291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-26b inhibits hepatocellular carcinoma cell proliferation, migration, and invasion by targeting EphA2.
    Li H; Sun Q; Han B; Yu X; Hu B; Hu S
    Int J Clin Exp Pathol; 2015; 8(5):4782-90. PubMed ID: 26191168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kruppel-like factor 6 suppresses growth and invasion of hepatocellular carcinoma cells in vitro and in vivo.
    Wen PH; Wang DY; Zhang JK; Wang ZH; Pan J; Shi XY; Yang H; Zhang SJ; Guo WZ
    Int J Immunopathol Pharmacol; 2016 Dec; 29(4):666-675. PubMed ID: 27510817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-induced exosomes promote hepatocellular carcinoma proliferation and metastasis via miR-1273f transfer.
    Yu Y; Min Z; Zhou Zhihang ; Linhong M; Tao R; Yan L; Song H
    Exp Cell Res; 2019 Dec; 385(1):111649. PubMed ID: 31562861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRG1 suppresses the migration and invasion of hepatocellular carcinoma cells.
    Zhang Y; Luo Q; Wang N; Hu F; Jin H; Ge T; Wang C; Qin W
    Med Oncol; 2015 May; 32(5):146. PubMed ID: 25814288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA MIR22HG inhibits growth, migration and invasion through regulating the miR-10a-5p/NCOR2 axis in hepatocellular carcinoma cells.
    Wu Y; Zhou Y; Huan L; Xu L; Shen M; Huang S; Liang L
    Cancer Sci; 2019 Mar; 110(3):973-984. PubMed ID: 30680848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.